• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Regulatory press release

Arctic Bioscience - Minutes of the Annual General Meeting

Arctic Bioscience
Download the release

The Annual General Meeting of Arctic Bioscience AS was held Wednesday 27 May 2026 at 11:00 (CET). All the items on the agenda were addressed and approved. Attached is the minutes of the Annual General Meeting.

Changes to the Board of Directors:

The General Meeting approved the change in the Board of Directors in accordance with the board's proposal, thus the Board of Directors will consist of the following people:

  • Tore A. F. Tønseth (chairperson)
  • Jan Endre Vartdal
  • Harald Nordal
  • Marita Holstad
  • Olav Sindre Kriken

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.